3F Therapeutics

company

About

3F Therapeutics develops, manufactures, and markets cardiovascular devices.

Details

Last Funding Type
Series B
Last Funding Money Raised
$14.20M
Industries
Biotechnology,Health Care,Manufacturing,Medical,Medical Device
Founded date
Jan 1, 1998
Operating Status
Active

3F Therapeutics develops, manufactures, and markets cardiovascular devices. It offers invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system to reduce surgical cross-clamp and cardio-pulmonary bypass time, utilization for congestive heart failure.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$20.20M
3F Therapeutics has raised a total of $20.20M in funding over 2 rounds. Their latest funding was raised on Apr 25, 2005 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 25, 2005 Series C $6M 1 Detail
Aug 12, 2004 Series B $14.20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3F Therapeutics is funded by 1 investors. Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Series C